Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
April 5, 2026Cancer Research

Abstract 5967: Overexpression of the transcription factor gene TGIF1 inhibits proliferation in NRAS-driven acute myeloid leukemia cells

View Full Paper
Ask AI
Bookmark
Share

Authors

MRMichael L. RobertsHCHerryung ChoiCWChase Mitchell Weizer

Discussion

Loading...

Member takes

Overview

The study shows that TGIF1 overexpression inhibits proliferation in NRAS-driven AML, suggesting a potential therapeutic target.

Key Points

  • This research aims to understand how TGIF1 affects the proliferation of AML cells and its potential role as a tumor suppressor.
  • Identified transcriptional regulators responsive to PMA treatment in HL-60 AML cells.
  • Utilized DNA microarray and RNA sequencing to analyze gene expression.
  • Conducted flow cytometric assays to measure cell proliferation via Ki67 and DNA content.
  • Performed Kaplan-Meier survival analysis to link TGIF1 levels with patient outcomes.
  • TGIF1 overexpression significantly inhibits proliferation in AML cell lines.
  • TGIF1 acts as a prognostic marker indicating greater overall survival in high expression samples.
  • TGIF1 inhibits MYC and CCND1 expression as part of its mechanism.

Cite This Study

Roberts et al. (2026) studied this question.

synapsesocial.com/papers/69d1fd29a79560c99a0a30e9https://doi.org/10.1158/1538-7445.am2026-5967
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract 1674: Inhibition of oncogenic nras signaling in acute myeloid leukemia cell lines through directed transcriptome alterations2024
  2. 2Abstract 5592: HMGA1 modulates chromatin state and transcriptional networks involved in plasticity in refractory myeloid leukemia2024
  3. 3Abstract 5589: <i>CBFB::MYH11</i> expression activates <i>Trp53</i> in myeloid cells, which inhibits cell growth and sensitizes cells to cytarabine2024
  4. 4ITGAM sustains MAPK signaling and serves as an adverse prognostic factor and therapeutic target in acute myeloid leukemia2024 · 3 citations
  5. 5FGF11–HIF-1α glycolytic epigenetic axis drives AML progression and chemoresistance via metabolic reprogramming2025